ArticleAlzheimer's & dementia (New York, N. Y.)

Integration of blood-based biomarkers and genomic variants identifies individuals with mild cognitive impairment who benefit from multidomain intervention.

Tetsuaki Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.